Differences in prevalence of antibodies to GAD and IA-2 and their titers at diagnosis in children with slowly and rapidly progressive forms of type 1 diabetes

Diabetes Research and Clinical Practice

Volumn 83, Issue 1, 2009, Pages 89-93

  Urakami, Tatsuhiko ^a   Yoshida, Ayako ^a   Suzuki, Junichi ^a   Saito, Hiroshi ^a   Wada, Mika ^a   Takahashi, Shouri ^a   Mugishima, Hideo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

GAD antibody; IA 2 antibody; Rapidly progressive form; Slowly progressive form; Type 1 diabetes in childhood

Indexed keywords

ANTIBODY; ANTIBODY TO GLUTAMIC ACID DECARBOXYLASE; ANTIBODY TO PROTEIN TYROSINE PHOSPHATASE IA 2; INSULIN; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL DAMAGE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPANESE; MAJOR CLINICAL STUDY; MALE; PREVALENCE;

ADOLESCENT; AUTOANTIBODIES; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; PREVALENCE; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8;

EID: 57849169481     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.09.050     Document Type: Article

References (26)

1. Kobayashi T., Sugimoto T., Itoh T., Kosaka K., Tanaka T., Suwa S., et al. The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin dependent diabetic patients studied by indirect immunofluolescence and by a new method. Diabetes 35 (1986) 335-340
2. Kobayashi T., Tanemoto K., Nakanishi K., Kato N., Okubo M., Kajio H., et al. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16 (1993) 780-788
3. The expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 21 (1998) 55-519.
4. Alberti K.G.M.M., Zimmer P.Z., and for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus. Provision report of a WHO Consultation. Diabet. Med 15 (1998) 539-553
5. Tuomi T., Groop L.C., Zimmet P.Z., Rowley M.J., Knowles W., and Mackay I.R. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42 (1993) 359-362
6. Zimmet P.Z., Tuomi T., Mackay I.R., Rowley M.J., Knowles W., Cohen M., et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet. Med. 11 (1994) 299-303
7. Urakami T., Miyamoto Y., Fujita H., and Kitagawa T. Type 1 (insulin-dependent) diabetes in Japanese children is not a uniform disease. Diabetologia 32 (1989) 312-315
8. Urakami T., Matsunaga H., Miyamoto Y., Owada M., and Kitagawa T. Serial changes in the prevalence of islet cell antibodies and islet cell antibody titer in children with IDDM of abrupt or slow onset. Diabetes Care 18 (1995) 1095-1099
9. Urakami T., Kubota S., Nitadori Y., Harada K., Owada M., and Kitagawa T. Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area. Diabetes Care 28 (2005) 1876-1881
10. Urakami T., Morimoto S., Nitadori Y., Harada K., Owada M., and Kitagawa T. Urine Glucose Screening Program at Schools in Japan to Detect Children with Diabetes and Its Outcome-Incidence and Clinical Characteristics of Childhood Type 2 Diabetes in Japan. Pediatr. Res. 61 (2007) 141-145
11. T. Reiehr, E. Schober, S. Wiegand, A. Thon, R. Holl, On behalf of the DPV-Wiss Study Group. Beta-cell auntoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification? Arch. Dis. Child. 91 (2006), 473-477.
12. Lohmann T., Nietzschmann U., and Kiess W. LADY-like: is there a latent autoimmune diabetes in the young?. Diabetes Care 23 (2000) 1707-1708
13. Hosszufalusi N., Vatay A., Rajczy K., Prohaszka Z., Pozsonyi E., Horvath L., et al. Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression. Diabetes Care 26 (2003) 452-457
14. Kobayashi T., Nakanishi K., Ohkubo M., Naruse T., and Kosaka K. GAD antibodies seldom disappear in slowly progressive IDDM. Diabetes Care 19 (1996) 1031
15. Sera Y., Kawasaki E., Abiru N., Ozaki M., Abe T., Takino H., et al. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening. J. Autoimmun. 13 (1999) 257-265
16. Kawaski E., and Eguchi K. Is type 1 diabetes in the Japanese population the same as among Caucasians?. Immunol Diabetes III 1037 (2004) 96-103
17. Yamada H., Uchigata Y., Kawasaki E., Matsuura N., Otani T., Sato A., et al. Onset age-dependent variations of three islet specific autoantibodies in Japanese IDDM patients. Diabetes Res. Clin. Pract. 39 (1998) 211-217
18. Notkins A.L., and Lernmark A. Autoimmune type 1 diabetes: resolved and unresolved issues. J. Clin. Invest. 108 (2001) 1247-1252
19. Pihoker C., Gilliam L.K., Hampe C.S., and Lernmark A. Autoantibodies in diabetes. Diabetes 54 (2005) S52-S61
20. Nakamoto S., Kasuga A., Maruyama T., Ozawa Y., Amemiya S., and Saruta T. Age of onset, not type onset, affects the positivity and evanescence of IA-2 antibody. Diabetes Res. Clin. Pract. 50 (2000) 147-152
21. Feeny S.J., Myers M.A., Mackay I.R., Zimmet P.Z., Howard N., Verge C., et al. Evaluation of ICA512As in combination with other islet cell autoantibodies at the onset of IDDM. Diabetes Care 20 (1997) 1403-1407
22. Graham J., Hagopian W.A., Kockum I., Li L.S., Sanjeevi C.B., Lowe R.M., et al. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 51 (2002) 1346-1355
23. Yamada K., Yuan X., Inada C., Hayashi H., Koyama K., Ichikawa F., et al. Combined measurements of GAD65 and ICA512 antibodies in acute onset and slowly progressive IDDM. Diabetes Res. Clin. Pract. 35 (1997) 91-98
24. Hathout E.H., Sharkey J., Racine M., Thomas W., Nahab F., EI-Shahawy M., et al. Diabetic autoimmunity in infants and pre-schoolers with type 1 diabetes. Pediatr. Diabet. 1 (2000) 131-134
25. Hathout E.H., Hartwick N., Fagoaga O.R., Colacino A.R., Sharkey J., Racine M., et al. Clinical, autoimmune, and HLA characteristics of children diagnosed with type 1 diabetes before 5 years of age. Pediatrics 111 (2003) 860-863
26. Borg H., Gottsater A., Fernlund P., and Sundkvist G. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 51 (2002) 1754-1762